EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Open Access · CC BY-NC 3.0

Revefenacin Area Under the Curve Spirometry in Patients with Moderate to Very Severe COPD

William Blake LeMaster, Corey J Witenko iD, Melinda K Lacy iD, Ann W Olmsted iD, Edmund J Moran, Donald A Mahler iD

International Journal of Chronic Obstructive Pulmonary Disease · 2024

DOI: 10.2147/copd.s483176 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2024. Verfasst von William Blake LeMaster und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Bronchodilator Agents, Spirometry, Lung. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Theravance Biopharma US, Inc., South San Francisco, CA, USA, Viatris, Inc., Canonsburg, PA, USA..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveBronchodilator AgentsSpirometryLungSeverity of Illness IndexHumansMaleForced Expiratory VolumeFemaleAgedMiddle AgedTreatment OutcomeTime FactorsCarbamatesAdministration, InhalationArea Under CurvePredictive Value of TestsDouble-Blind MethodBenzamidesMuscarinic AntagonistsRecovery of FunctionClinical Trials, Phase III as Topic

Stichwörter der Autor:innen

Bronchodilatorsforced expiratory volume in 1 secondlong-acting muscarinic antagonistoutcome measuresspirometry

Substanzen

Bronchodilator AgentsrevefenacinCarbamatesBenzamidesMuscarinic Antagonists

Autor:innen und Institutionen

  • Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Theravance Biopharma US, Inc, South San Francisco, CA, USA.
  • Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
  • Respiratory Services, Valley Regional Hospital, Claremont, NH, USA.

ORCID-Profile: Corey J Witenko, Melinda K Lacy, Ann W Olmsted, Donald A Mahler

Förderung

  • Theravance Biopharma US, Inc., South San Francisco, CA, USA
  • Viatris, Inc., Canonsburg, PA, USA.

Zitieren

APA

LeMaster, W. B., Witenko, C. J., Lacy, M. K., Olmsted, A. W., Moran, E. J., & Mahler, D. A. (2024). Revefenacin Area Under the Curve Spirometry in Patients with Moderate to Very Severe COPD. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s483176

Vancouver

LeMaster WB, Witenko CJ, Lacy MK, Olmsted AW, Moran EJ, Mahler DA. Revefenacin Area Under the Curve Spirometry in Patients with Moderate to Very Severe COPD. International Journal of Chronic Obstructive Pulmonary Disease. 2024. doi:10.2147/copd.s483176

BibTeX
@article{LeMaster2024,
  author = {LeMaster, William Blake and Witenko, Corey J and Lacy, Melinda K and Olmsted, Ann W and Moran, Edmund J and Mahler, Donald A},
  title = {Revefenacin Area Under the Curve Spirometry in Patients with Moderate to Very Severe COPD},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2024},
  doi = {10.2147/copd.s483176}
}
Kostenlos starten →